S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › NBB › Research report
← NBB page
XStocksXray
Market X-Ray report · 20 October 2026

Norman Broadbent Plc (NBB)

London Exchange · UK · prices in GBX · close of 20 Oct 2026

Key indicators

Last closeGBX 230.00
52-week range170.00 – 260.00
Return, 1 month / 3 months+14.4% / +22.7%
Return, 1 year / 3 years−8.9% / –
TrendUptrend
RSI (14)71
Volatility (1 year)20.7%
Worst drawdown (1 year)-31.7%
Average daily value traded1.02M GBX
Dividend yield–

Market X-Ray price-based

59/ 100 · High confidence · ahead of 63% of stocks on this exchange
Trend61
Momentum56
Stability (higher is calmer)65
Liquidity53
Income–

Five-year price chart navy: price · brown: 200-day average

74.411522293073842021-102023-082025-042026-012026-10

About the company

Norman Broadbent Plc is a London-based executive search and recruitment business. It helps organisations find senior leaders and board members, and it also supplies interim managers and provides leadership advisory and assessment services. Its clients are companies and other organisations seeking executive talent, drawn from sectors such as financial services, industry and consumer markets. The firm works on retained search assignments and related people services for clients in the United Kingdom and internationally.

Norman Broadbent Plc trades under the code NBB on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Norman Broadbent Plc (NBB) trades on the London Exchange in UK. It last closed at GBX 230.00 on 20 October 2026.

Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,389 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 8.9% and over the last three months it rose 22.7%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Norman Broadbent Plc (NBB)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend61 · FairMixed trend against its averages.
Above 200-day average8.6%
From 52-week high-8.9%
Momentum56 · FairTypical recent returns for this exchange.
3-month return22.7%
6-month return4.1%
12-month return, skipping the last month-20.4%
Stability (higher is calmer)65 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)20.7%
Worst drawdown, 1 year (smaller is calmer)-31.7%
Liquidity53 · FairModerate trading activity.
Average daily value traded1.02M GBX
Zero-volume days20.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

No lens is weak against its exchange.

Returns

1 week−1.3%
1 month+14.4%
3 months+22.7%
6 months+4.1%
1 year−8.9%
3 years–
5 years–

Signals

50-day / 200-day average209.16 / 211.83
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)5.03

Technical summary

DailyStrongly bullish11 bullish · 3 neutral · 2 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026